|

Propranolol Clinical Trials

8 actively recruiting trials across 3 locations

▼ -1 trial since May 2026

Also known as: 1-[(1-Methylethyl)amino]-3-(1-naphthalenyloxy)-2-propanol, Betablocker, Inderal, Propal

Pipeline

Phase 1: 1Phase 2: 3Phase 2/3: 1

Top Sponsors

  • Zealand University Hospital1
  • West China Hospital1
  • Sarah Weiss1
  • Roswell Park Cancer Institute1
  • Niels Junker1

Indications

Other5 trials

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
Phase 2
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
Phase 2/3
Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC.
Phase 2
Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Phase 2
Propranolol and Von Hippel-Lindau Disease
N/A

Basking Ridge, New Jersey1 trial

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

N/A

New Brunswick, New Jersey1 trial

Naltrexone and Propranolol Combined With Immunotherapy

Rutgers Cancer Institute of New Jersey

Phase 1

Buffalo, New York1 trial

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Roswell Park Cancer Institute

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.